Preeclampsia Foundation

Analysis

Preeclampsia Foundation is a registered charity in United States, based in Melbourne, FL. It received its IRS tax-exemption ruling in August 2001, 25 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Preeclampsia Foundation reported income of $2.2m and spending of $1.7m, leaving 22% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $1.3m to $2.2m (+71%), an average of +14% a year. The sharpest change came in the year to December 2023, when income rose by 37%. Over the whole period it spent 86% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Preeclampsia Foundation sits at the 72nd percentile: it is larger than about 72% of them. Against every charity in United States with reported income it ranks in the 87th percentile, and in the 88th percentile within FL. Charities of a similar size with the same main cause include Cultiva LA Salud ($2.2m), Institute for Medicaid Innovation Inc ($2.2m) and The Autism Community in Action ($2.2m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 68% and program service revenue 21% of the total. Compensation of current officers, directors and key employees was $102k (6.1% of expenses). Other salaries and wages came to $499k. At year end it held assets of $2.3m against liabilities of $293k, net assets of $2.1m. It reported 14 employees.